Skip to main content
Clinical Trials/CTRI/2024/06/069652
CTRI/2024/06/069652
Not yet recruiting
未知

Evaluation of dermatological safety of test products by 24 hours patch test under complete occlusion, semi occlusion, open patch on adult healthy human subjects. - NI

Kayura Effect LLP0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kayura Effect LLP
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Kayura Effect LLP

Eligibility Criteria

Inclusion Criteria

  • 1\) Age: 18\-65 years (both inclusive) at the time of consent.
  • 2\)Sex: Males and non\-pregnant/non\-lactating females (preferably an
  • equal number of males and females).
  • 3\) Subject with normal Fitzpatrick skin type III to V (Human skin colour determination
  • 4\) Females of childbearing potential must have a self\-reported negative pregnancy test.
  • 5\) Subject who do not have any previous history of adverse skin conditions and are not
  • under any medication likely to interfere with the results.
  • 6\)Subject is in good general health as determined by the Investigator on the basis of medical history.
  • 7\) Subjects is willing to maintain the test patches in designated positions for 24 Hours.
  • 8\) Subject is willing and able to follow the study directions, to

Exclusion Criteria

  • 1\) Subject having skin irritation, blemishes, excessive hair, moles,
  • pigmentation, pimples, marks (e.g. tattoos (within the previous 3
  • months), scars, sunburn), open wounds, cuts, abrasions, irritation
  • symptoms or any dermatological condition on the test site(s) i.e.
  • back that can interfere with the reading.
  • 2\) Medication which may affect skin response and/or past medical
  • 3\) Subject having history of diabetes
  • 4\) Subject have history of mastectomy for cancer involving removal
  • of lymph nodes within the past year, or treatment of any type of
  • cancer within the last 6 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials